Embraer's 2026 Outlook: Record $34.5 billion Backlog Drives Future Production Growth

Embraer exited 2Q26 with a record $34.5 billion backlog—roughly a four-year delivery pipeline—after seven consecutive quarters of demand growth, while delivering 65 aircraft in the strongest second quarter in 16 years. Its sub-150-seat commercial-jet niche, 10.7% six-year services CAGR, and new KC-390 defense contracts support the growth outlook, but supply-chain constraints pressured operating margins to about 8% in 2025 and adjusted free cash flow declined 11.55%. Shares have risen 29% over the past year and trade at elevated valuation metrics, including 15.41x EV/EBITDA and a 1.66x price-to-sales ratio.

Analysis

EMBJ’s valuation now leaves the equity more exposed to conversion of backlog into cash than to incremental order announcements. The key earnings torque is supplier normalization: recovering roughly 200-300bp of operating margin toward prior levels would materially alter FY27-FY28 FCF expectations, while another year of working-capital absorption would expose the gap between reported delivery growth and cash generation. Airbus (AIR) and Boeing (BA) capacity constraints indirectly improve Embraer’s pricing leverage with airlines seeking near-term lift, but engine/avionics bottlenecks are a shared constraint rather than a company-specific advantage.

The underappreciated asset is installed-base monetization. Higher fleet utilization and aging regional fleets should lift parts, maintenance and training revenue faster than airframe revenue over the next 6-18 months; this mix shift can defend consolidated margins even if new-aircraft production remains constrained. KC-390 export wins create a separate, longer-duration re-rating path, but defense awards are lumpy and sovereign-financing dependent, so the market should not capitalize preliminary demand at commercial-aircraft multiples.

Near term, the stock is vulnerable to a delivery or margin miss because sentiment and the revenue multiple already embed clean execution. A better entry likely follows evidence of supplier recovery—two consecutive quarters of delivery guidance attainment, inventory/advance-payment normalization, and positive FCF conversion—rather than further backlog growth. Contrarian view: a broad aerospace supply-chain disruption would likely hurt EMBJ less than BA operationally, but EMBJ’s smaller liquidity profile and Brazil risk could still produce sharper multiple compression in a risk-off tape.

Key Decisions for Investors

• Maintain EMBJ as a watch-to-accumulate long, not a chase: initiate only on a 10-15% execution-driven pullback or after two quarters of delivery and FCF conversion above guidance; target 12-18 months, with upside driven by margin recovery and services mix rather than backlog expansion.
• Use a relative-value position long EMBJ / short BA over 6-12 months for exposure to regional-jet substitution and less company-specific certification/production risk at Boeing. Falsify if EMBJ cuts annual deliveries or if BA demonstrates sustained monthly production stability and improving 737 cash conversion.
• Do not underwrite EVEX as a look-through EMBJ catalyst until certification milestones, binding purchase commitments, and funding requirements are independently disclosed. Treat any EVEX strength on eVTOL narrative as an opportunity to avoid or hedge, given dilution and certification-duration risk.
• Set a quarterly alert on EMBJ operating margin, free-cash-flow conversion, and supplier-related delivery commentary: margin below ~8% with falling FCF would warrant reducing exposure; sustained progress toward double-digit margin supports adding despite the elevated multiple.